Analgesics
Antiandrogens
Antihistamines
Azvudine
Bromhexine
Budesonide
Colchicine
Conv. Plasma
Curcumin
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Ivermectin
Lifestyle
Melatonin
Metformin
Minerals
Molnupiravir
Monoclonals
Naso/orophar..
Nigella Sativa
Nitazoxanide
PPIs
Paxlovid
Quercetin
Remdesivir
Thermotherapy
Vitamins
More

Other
Feedback
Home
Top
Abstract
All molnupiravir studies
Meta analysis
 
Feedback
Home
next
study
previous
study
c19early.org COVID-19 treatment researchMolnupiravirMolnupiravir (more..)
Melatonin Meta
Metformin Meta
Antihistamines Meta
Azvudine Meta Molnupiravir Meta
Bromhexine Meta
Budesonide Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta PPIs Meta
Famotidine Meta Paxlovid Meta
Favipiravir Meta Quercetin Meta
Fluvoxamine Meta Remdesivir Meta
Hydroxychlor.. Meta Thermotherapy Meta
Ivermectin Meta

All Studies   All Outcomes    Recent:   

Could a popular COVID-19 antiviral supercharge the pandemic?

Service, R., Science, doi:10.1126/science.adg9677
Feb 2023  
  Post
  Facebook
Share
  Source   PDF   All Studies   Meta AnalysisMeta
Coverage of1,2 which show evidence for molnupiravir creating new variants. The quote "Right now, it’s much ado about nothing" is from Emory University, where Molnupiravir was invented3 (COI not mentioned).
Service et al., 1 Feb 2023, preprint, 1 author.
This PaperMolnupiravirAll
{ 'indexed': {'date-parts': [[2023, 2, 2]], 'date-time': '2023-02-02T05:45:28Z', 'timestamp': 1675316728711}, 'reference-count': 0, 'publisher': 'American Association for the Advancement of Science (AAAS)', 'content-domain': {'domain': [], 'crossmark-restriction': False}, 'published-print': {'date-parts': [[2023, 2, 1]]}, 'DOI': '10.1126/science.adg9677', 'type': 'dataset', 'created': {'date-parts': [[2023, 2, 1]], 'date-time': '2023-02-01T22:40:58Z', 'timestamp': 1675291258000}, 'source': 'Crossref', 'is-referenced-by-count': 0, 'title': 'Could a popular COVID-19 antiviral supercharge the pandemic?', 'prefix': '10.1126', 'member': '221', 'container-title': 'AAAS Articles DO Group', 'original-title': [], 'deposited': { 'date-parts': [[2023, 2, 1]], 'date-time': '2023-02-01T22:40:59Z', 'timestamp': 1675291259000}, 'score': 1, 'resource': { 'primary': { 'URL': 'https://www.science.org/content/article/could-popular-covid-19-antiviral-supercharge-pandemic'}}, 'subtitle': [], 'short-title': [], 'issued': {'date-parts': [[2023, 2, 1]]}, 'references-count': 0, 'URL': 'http://dx.doi.org/10.1126/science.adg9677', 'relation': {}, 'published': {'date-parts': [[2023, 2, 1]]}}
Loading..
Please send us corrections, updates, or comments. c19early involves the extraction of 100,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit